Events

Home Events

23

Feb2018

Québec Gazette Announces Draft Regulations for Implementation of Fees for INESSS Submissions

/ INESSS, Quebec, What's New
On February 21, 2018, the Gazette officielle du Québec announced that draft regulations, relating to the implementation of fees for ... Read More

14

Feb2018

CADTH Common Drug Review Releases New Update

/ CADTH, What's New
On February 13, 2018, the Canadian Agency for Drugs and Technologies in Health (CADTH) released a new CDR Update ... Read More

08

Feb2018

The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update

/ pCPA, What's New
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of January 31, 2018: ... Read More

07

Feb2018

PMPRB Form 3 (R&D) Due Date Reminder

/ PMPRB, What's New
This is a reminder to patentees of their filing requirements respecting revenues and development expenditures. These filing requirements are contained ... Read More

01

Feb2018

NEW PDCI Report finds Health Canada significantly overstates benefits & underestimates negative impact of its proposed regulatory amendments

/ News, PDCI, What's New
On January 29, 2018, PDCI released a report critically evaluating Health Canada’s plan to change how patented medicine prices ... Read More

30

Jan2018

INESSS Releases Additional Information – Requests for Changes of an Administrative Nature

/ INESSS, Quebec, What's New
On January 29, 2018, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers. ... Read More

22

Jan2018

PMPRB myth busting (I): The imaginary link between Canadian price controls and R&D expenditures

/ Blog, What's New
The myth perpetuated by government and academics – and echoed in the media – is that the Patented Medicine Prices ... Read More

15

Jan2018

The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update

/ What's New
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of December 31, 2017: ... Read More